MYRIAD
Myriad Group AG (SIX Swiss Exchange: MYRN) the company creating and connecting communities across mobile, today announced that it has partnered with ChangeCorp to support the SmartWoman Project. Under the agreement, Myriad’s msngr channels will provide the platform for the SmartWoman Project, which is a mobile magazine designed to engage, build community, reach, educate and empower women across Latin America and Africa.
SmartWoman is a ground-breaking initiative with a clear mission to eliminate the barriers to education for women. SmartWoman empowers women to build important life skills by extending access to information, community, and development support across areas such as leadership, money management, parenting and entrepreneurship. Providing a platform for access and sharing, Myriad’s msngr channels will offer a dedicated community that extends the reach of the project.
ChangeCorp’s SmartWoman project is endorsed by the International Telecommunications Union and the UN Women.
Stephen Dunford, CEO of Myriad Group AG, commented: “msngr is committed to building and supporting communities and is proving that as a platform it can be used by not just brands but by anyone working to build and reach a community with content and information. With our focus on Latin America and emerging markets it is exciting to see the social, mobile and local nature of msngr both complimenting and hopefully furthering the SmartWoman empowerment project.”
Louise Guido, CEO of ChangeCorp and the developers of SmartWoman mobile platform, said: “We believe that in many emerging markets users want localised content, to connect with each other under a common platform, and both msngr and SmartWoman achieve those specific goals. Helping people connect one-on-one to share experiences, expand their knowledge and impact their lives is exactly what we do everyday with not only SmartWoman, but with all of our mobile services. msngr is the perfect partner to extend this mission.”
msngr is completely free when a user is on a partner network and is available to anyone with a data enabled mobile phone, from feature phones to the latest smart phones.
-ENDS-
About Myriad
Myriad delivers consumer applications, messaging solutions, and embedded software to leading OEMs, mobile operators, and pay TV providers worldwide. Our messaging services deliver instant messaging and social networking to tens of millions of users in Latin America, Asia and Africa. Working with some of the world’s most successful mobile phone operators, Myriad’s market leading chat application, msngr, enables consumers to connect to friends and family for free across feature phones as well as smartphones. Our Updates service, provided over USSD through our collaboration with Facebook and Twitter enables users without data plans to connect to the social networks and chat services they want to reach in a simple and affordable way. In many cases, Myriad’s services are providing users with their first experience of the Internet.
Our market proven and innovative connected home solutions are found in billions of mobile phones and tens of millions of set-top boxes and Blu-ray players.
We operate worldwide, with offices in Switzerland, UK, France, USA, Mexico, India, UAE, China, Japan. Headquartered in Zurich, Switzerland, Myriad is listed on the SIX Swiss Exchange (SIX Symbol: MYRN).
For more information please visit our website: www.myriadgroup.com . You can also follow us on twitter @MyriadGroup.
Contact:
MUSTARD PR
Andrew Durkin
+ 44 (0) 7887 998407
myriad@mustardpr.com
or
Myriad
Investor Relations
Peter McCormack
Tel: +44 (0) 161 817 8075
Investor_relations@myriadgroup.com
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
AwardFares Launches Intelligent New Alert System for Award Flight Availability5.8.2025 08:00:00 CEST | Press release
AwardFares, the leading search platform for award flights, today launched a major upgrade to its alert system, giving users smarter tools to discover and book award availability faster. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250804412041/en/ AwardFares' Timeline view provides a clear, color-coded visualization of daily award seat availability across different cabin classes, helping users easily spot trends and opportunities for flights. The new system includes two powerful features: Flex Alerts and Live Alerts. Together, they provide both flexibility and precision, helping travelers maximize their points and miles like never before. Flex Alerts are designed for the flexible traveler. Instead of requiring an exact route and date, users can set broad criteria such as "any airport in the US to Europe for an entire month.” AwardFares' AI-powered system intelligently identifies matching availability, focusing not just on
Venture Global Calcasieu Pass Receives Uprate Approval from U.S. Department of Energy5.8.2025 02:02:00 CEST | Press release
Today, Venture Global, Inc. (NYSE: VG) received approval from the U.S. Department of Energy (DOE) for an uprate amendment to its Calcasieu Pass LNG project. The uprate approval increases Calcasieu Pass’ permitted peak liquefaction capacity from 12.0 million tonnes per annum (MTPA) to 12.4 MTPA. “Venture Global thanks its regulators, including DOE, for their efforts in prioritizing and streamlining approvals for critical energy infrastructure projects. These multibillion dollar investments will be key as the United States strengthens global energy security and increases energy trade with our partners around the world,” said Venture Global CEO Mike Sabel. Calcasieu Pass, Venture Global’s first project, reached first LNG production in 2022 and began commercial operations in April 2025. The company’s second facility, Plaquemines LNG, began LNG production in December 2024. Venture Global’s third project, CP2, received DOE export authorization and FERC approval in March 2025 and May 2025, re
Vertex Announces Results from Phase 2 Study of VX-993 for the Treatment of Acute Pain4.8.2025 22:01:00 CEST | Press release
– Treatment with the selective NaV1.8 pain signal inhibitor VX-993 after bunionectomy surgery did not meet the primary endpoint –– Treatment with VX-993 was generally safe and well tolerated, with safety profile similar to placebo arm – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced topline results from its recently completed Phase 2, randomized, double-blind, placebo-controlled dose-ranging study evaluating the safety and efficacy of its investigational selective NaV1.8 pain signal inhibitor, VX-993, in treating acute pain after bunionectomy surgery. Treatment with VX-993 did not result in a statistically significant improvement on the primary endpoint of the time-weighted Sum of the Pain Intensity Difference from 0 to 48 hours (SPID48) compared to placebo. VX-993 was generally safe and well tolerated. Most adverse events (AEs) were mild to moderate, and there were no serious adverse events (SAEs) related to VX-993. Based on these results, Vertex will not progress
TOURISE Announces Cross-Sector Advisory Board to Champion Bold New Platform Rewriting the Rules of Tourism4.8.2025 20:53:00 CEST | Press release
Leaders from World Travel & Tourism Council (WTTC), Global Sustainable Tourism Council, Amadeus, TikTok, Six Senses, Cirque du Soleil, Turismede Barcelona, Liberty International, Wagonlit Travel, Once Billion Happy, the Saudi Tourism Authority (STA), and the Riyadh School of Tourism and Hospitality at the helm of TOURISE Advisory Board Formation of the Advisory Board reinforces TOURISE’s dedication to driving cross-sector global collaboration Advisory Board shape TOURISE summit agenda, ensuring high-impact global issues such as equity, geographical representation and sectoral diversity are in spotlight TOURISE, the bold new global tourism platform, has announced the members of its cross-sector Advisory Board, a powerhouse of industry titans guiding TOURISE’s strategic direction and shaping the agenda of the inaugural global summit taking place in Riyadh from 11-13 November, 2025. TOURISE is where cross-sector convergence begins, a platform where leaders and visionaries debate, collabor
Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe4.8.2025 20:38:00 CEST | Press release
Concept Medical Inc., a global pioneer in drug-delivery technologies, announced the enrollment of the first patient in the MAGICAL-SV (MAGIcTouch™ Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels) trial, a U.S. Investigational Device Exemption (IDE) study evaluating its MagicTouch™ sirolimus-coated balloon (SCB) for the treatment of small coronary vessels. This first U.S. enrollment follows the FDA’s IDE approval of MagicTouch SCB, marking a major milestone in Concept Medical’s mission to revolutionize coronary artery disease (CAD) treatment and expand its clinical program into the US and Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250804524652/en/ Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Study Dr. Samin Sharma enrolled the first patient at New York’s Mount Sinai Hospital, Director of Interventional Cardiology, marking a crucial step in advancing treatm
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum